or Try an Advanced Search...
    Invalid date chosen. Displaying data for the latest date instead.

    Technical Analysis for KA - Kineta, Inc.

    Grade Last Price % Change Price Change
    F 0.46 -1.43% -0.01
    KA closed down 1.43 percent on Friday, May 24, 2024, on 4 percent of normal volume.
    Earnings due: Jun 6
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical KA trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Hammer Candlestick Bullish -1.43%
    NR7 Range Contraction -1.43%
    Narrow Range Bar Range Contraction -1.43%
    Wide Bands Range Expansion -1.43%
    Narrow Range Bar Range Contraction -3.05%
    Inside Day Range Contraction -3.05%
    Wide Bands Range Expansion -3.05%
    Wide Bands Range Expansion -1.52%
    Wide Bands Range Expansion -4.10%
    Older End-of-Day Signals for KA ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance 4 days ago
    Hammer Candlestick Entry 4 days ago
    Rose Above Previous Day's High 4 days ago
    Rose Above 10 DMA 4 days ago
    Up 3% 4 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    KA Chart by TradingView
    Basic chart:

    Profile

    Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, and Wellcome. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Neuroscience Immunotherapies

    Is KA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Kineta GAAP EPS of -$0.89
    May 15 Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
    Apr 15 Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Apr 9 Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 8 Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
    Mar 21 Kineta GAAP EPS of -$1.28 beats by $0.12, revenue of $5.44M misses by $0.15M
    Mar 21 Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
    Mar 12 KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported
    Feb 29 Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Feb 29 Crude Oil Moves Higher; Best Buy Posts Upbeat Earnings
    See more KA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.39
    52 Week Low 0.3339
    Average Volume 406,086
    200-Day Moving Average 2.28
    50-Day Moving Average 0.53
    20-Day Moving Average 0.53
    10-Day Moving Average 0.48
    Average True Range 0.07
    RSI (14) 38.65
    ADX 19.63
    +DI 13.16
    -DI 20.92
    Chandelier Exit (Long, 3 ATRs) 0.43
    Chandelier Exit (Short, 3 ATRs) 0.61
    Upper Bollinger Bands 0.63
    Lower Bollinger Band 0.42
    Percent B (%b) 0.18
    BandWidth 39.24
    MACD Line -0.04
    MACD Signal Line -0.04
    MACD Histogram -0.0003
    Fundamentals Value
    Market Cap 4.79 Million
    Num Shares 10.4 Million
    EPS -10.54
    Price-to-Earnings (P/E) Ratio -0.04
    Price-to-Sales 4.61
    Price-to-Book 9.27
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.53
    Resistance 3 (R3) 0.53 0.51 0.52
    Resistance 2 (R2) 0.51 0.49 0.51 0.52
    Resistance 1 (R1) 0.49 0.48 0.48 0.49 0.51
    Pivot Point 0.46 0.46 0.46 0.46 0.46
    Support 1 (S1) 0.44 0.45 0.43 0.44 0.41
    Support 2 (S2) 0.42 0.43 0.42 0.41
    Support 3 (S3) 0.39 0.42 0.40
    Support 4 (S4) 0.39